BioSpace News Archive

Daewoong Pharmaceutical (Daewoong) has confirmed promising phase 3 topline results that focuses on the therapeutic effects as an Enavogliflozin monotherapy and a combination therapy with Metformin. Daewoong’s Enavogliflozin is an SGLT-2 inhibitor in development for the first time in Korea.

Applied BioMath (www.appliedbiomath.com), the industry-leader in applying systems pharmacology and mechanistic modeling, simulation, and analysis to de-risk drug research and development, today announced their ongoing collaboration with Monte Rosa Therapeutics to develop a cellular systems pharmacology model for cereblon (CRBN)-based molecular glue degraders (MGDs) targeting GSPT1.

Alira Health (www.alirahealth.com), a global healthcare consulting and technology firm, announced that it has acquired Self Care Catalysts, Inc., a digital health company headquartered in Toronto, Canada

Personal Genome Diagnostics Inc. (PGDx), a leader in cancer genomics, today announced an update to the Proprietary Laboratory Analyses (PLA) code for its comprehensive genomic profiling test, PGDx elio™ tissue complete.

Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, announces that HonorHealth has established a robotic electrophysiology program as part of its Cardiovascular Center of Excellence at HonorHealth Scottsdale Shea Medical Center in Scottsdale, Arizona.

Glytec, the only provider of cloud-based insulin management software across the continuum of care, today announced a new strategic partnership with Nebraska Medicine to advance patient safety and innovation around insulin management.

Houston Health Department (HHD) announces minority-owned, Houston-based media and creative business firm 9thWonder Agency as its partner to help move the needle for the COVID-19 vaccine

Millennia (the “Company”), a leader in patient payment and patient engagement for hospitals, health systems and medical groups, is excited to announce the addition of Ankit Sharma to its leadership team as the Chief Data and Analytics Officer.

Exabel, the alternative data analytics platform for investment teams, and MedMine, a leading source of medical devices and hospital supplies procurement data, are delighted to announce a partnership that sees the creation of the MedMine Insights Platform.

Herophilus, a leading biotechnology company developing neurotherapeutics to cure complex brain diseases, announced the appointment of Brad Savall, Ph.D. as the company’s new Vice President and Head of Chemistry.